HOME >> BIOLOGY >> NEWS
UNC Center for Genome Sciences to inaugurate new seminar series with help of national experts

CHAPEL HILL -- The University of North Carolina at Chapel Hills new Center for Genome Sciences will kick off a seminar series on functional genomics, proteomics and bioinformatics Aug. 27 with a talk by Dr. Oliver Smithies, one of the universitys most distinguished scientists.

More than a dozen other national experts in those fields will follow during the 2001-2002 academic year. Smithies address is titled Mouse Solutions to Pharmacological Problems. He is excellence professor of pathology and laboratory medicine at the UNC School of Medicine. He also is developer of gene targeting, a renowned technique that allows scientists to disable genes in mice and breed successive generations of the animals to learn what role genes play in mammals, including humans.

Talks are free, and the public is encouraged to attend. All but the Oct. 1 presentation will be held on Mondays from noon to 1:30 p.m. in Room 136 of the Tate-Turner-Kuralt Building, located off Pittsboro Street. Genomics and proteomics are studies of information in genes and proteins, respectively, and bioinformatics is the science of handling and using biological data.

This is an exciting opportunity for the university community and the public to hear from some of the nations top scientists about the revolution in our current understanding of what genes and proteins do, said Dr. Harold L. Kohn. Kenan professor of medicinal chemistry at the school of pharmacy, Kohn co-chairs the new seminar series with Dr. Jeffrey L. Dangl, John N. Couch professor of biology.

The Human Genome Project is nearly complete, Kohn said. It has provided a wealth of sequence information leading to identification of all known genes. Similarly, rapid progress is being made to sequence the genetic material of known pathogens and organisms that affect life and well being.

The next challenge will be to provide meaning to this vast catalog of information, a challenge orders of magnitude more difficult than th
'"/>

Contact: David Williamson
David_Williamson@unc.edu
University of North Carolina at Chapel Hill
16-Aug-2001


Page: 1 2 3

Related biology news :

1. NIH awards $18.2m to The Burnham Institute to develop Center on Proteolytic Pathways
2. Joslin Diabetes Center honors brothers living 70-plus years with type 1 diabetes
3. K-States National Agricultural Biosecurity Center receives $1.3 Million from Department of Defense
4. Joslin Diabetes Center adds first affiliate in California at Irvine Medical Center
5. NHGRI launches Centers for Excellence in Ethical, Legal, and Social Implications Research
6. NIGMS funds Center for Quantitative Biology
7. Joslin Diabetes Center launches research section on developmental and stem cell biology
8. Joslin Diabetes Center releases new low impact exercise video
9. Workforce achievements celebrated at NASA Marshall Center Awards ceremony
10. National Bioinformatics Resource Center to support infectious disease research
11. National Parkinson Foundation designates UNC as Center of Excellence

Post Your Comments:
(Date:7/25/2014)... a pleiotropic factor characterized by the existence of ... that confer to the protein deeply different characteristics. ... myelination occurring during development and the different phases ... degeneration, axon regrowth, remyelination and target reinnervation, Researchers ... that the soluble NRG1 upregulation observed in Schwann ...
(Date:7/25/2014)... of a molecular testing panel developed at UPMC ... initial surgery for patients with thyroid nodules and ... Cancer Institute (UPCI), partner with UPMC CancerCenter., The ... and other diagnostic testing agencies, improved the chances ... 30 percent, according to the study published this ...
(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4
(Date:7/24/2014)... MENLO PARK, Calif. , July 24, 2014 ... biotechnology company in the emerging field of regenerative ... live webcast of a presentation to investors on ... 1:30 p.m. PDT.  The presentation will include an ... pipeline. To access the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics ...
(Date:7/24/2014)... Yet, scientists are making progress in devising suitable ... approach relies on quantum dotsa kind of artificial ... A new study demonstrates that changing the coupling ... electrical impulses can help better control them. This ... as quantum information units, which would produce faster ...
(Date:7/24/2014)... 24, 2014 Research and Markets ... and Proteomics Analytical Instruments Market 2014-2018" report to ... Genomics is the study of the gene ... the structure and functions of proteomes or sets of ... technology. Genomics involves the mapping of genes and DNA ...
(Date:7/24/2014)... Three companies from the angelMD network were ... Competition. Out of 700 competition entrants, Chiron Health, Litesprite, ... round. In this round twenty teams are invited to ... mentoring from thought-leaders and medical entrepreneurs from all over ... commitment to the Livestrong vision around the Big C ...
Breaking Biology Technology:Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 23 angelMD Startups Make Livestrong Big C Semi-finals 2
Cached News: